Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Actusnews Wire
563 Leser
Artikel bewerten:
(2)

BOIRON: 2021 results

The Board of Directors of BOIRON, at its meeting on March 9, 2022 chaired by Thierry Boiron, made up the statutory and consolidated financial statements of the financial year ended on December 31, 2021. It was decided to call a Shareholders' Meeting on May 19, 2022 at the company's headquarters in Messimy.

Audit of the statutory and consolidated financial statements have been performed and the audit reports concerning their certification are currently in the process of being issued.

BOIRON GROUP RESULTS

In thousands of euros20212020Variation
Sales(1)455,201513,582-11.4%(2)
Operating income46,84238,185+22.7%
Net income - Group share28,55626,209+9.0%
Cash flow(3)55,639104,944-47.0 %
Net investments11,92119,336-38.3%
Net cash position234,082234,313-0.1%

(1) The main information on the variation of the yearly sales were the subject of a financial statement on January 20, 2022 (https://www.boironfinance.fr/en/releases/sales).
(2) -10.6% at constant exchange rate.
(3) Before cash revenue, financing expenses and corporate income tax.

Full-year operating income amounted to €46,842 thousand. Despite the decline in sales, it benefited from the launch of new products and the implementation of a global savings plan.

The reorganisation plan in France is being implemented as planned. In 2021 it gave rise to a disbursement of €15,510 thousand. The remainder of the provision amounted to €43,241 thousand at December 31, 2021. The impacts of the reorganisation costs on operating income were as follows:

In thousands of euros20212020
Operating income46,84238,185
Net impact of reorganisation-1,290-32,719
Operating income before impact of reorganisation48,13270,904
% of revenue10.6%13.8%

As such, before accounting for the impact of reorganisation costs, 2021 operating income amounted to €48,132 thousand, owing to:

  • the decrease in revenues, which had a €67,120 thousand negative impact on the gross margin (following the delisting of homeopathy from French health insurance on January 1, and the absence of winter illnesses in the first quarter due to the global health crisis),
  • the reduction in preparation and distribution costs following the reorganisation in France and the ongoing implementation of a global savings plan, resulting in a €37,510 thousand reduction in overall operating expenses,
  • the €6,838 thousand increase in gains on disposals following the sale of eight preparation and distribution facilities.

The Board of Directors will recommend that the General Meeting of Shareholders distribute a dividend of 0.95 euros per share. The dividend will be paid out on June 3, 2022.

As announced in the January 20 release, on February 28, Laboratoires Boiron purchased 70% of the share capital of ABBI, a start-up specialising in personalized and customized cosmetics.

Due to a resurgence in winter illnesses, the impact of new product launches, and continued sales of COVID tests in the first months of the year, we expect to post sales growth in 2022.

However, Group sales will potentially be impacted by the war in Ukraine that began at the end of February 2022. It is of concern to all of our teams and affects our Ukrainian distributor, leading us to set up a crisis committee to manage the social and economic impacts of the situation on our distributor and our Russian subsidiary's activities. Sales generated in Ukraine and Russia in 2021 accounted for less than 4% of Group revenues. We are keeping a close eye on the situation, in order to take the necessary actions for organizing our operations.

We continue to put all our energy and determination into the promotion of Homeopathy in France and around the world.

Laboratoires BOIRON

Our next update:
April 21, 2022, at market close, publication of quarterly sales and financial information as of March 31, 2022.
Person responsible for financial information: Valérie Lorentz-Poinsot
Contact for financial information: Fabrice Rey
Investor relations: +33 (0) 4.37.41.84.01 - e-mail: boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at: www.boironfinance.com

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: x2dulZhsk2eXmHFslcdqb2VpaWmSk2HHm2SYmWNslJaabnBoyJtqbsXGZnBkmmhn
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-73531-boi-090322-ra-21-gb.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2022 Actusnews Wire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.